Significant pathways [27/95] pathways contains significant subpathways MAPK signaling pathway (hsa04010)
Chemokine signaling pathway (hsa04062)
Oocyte meiosis (hsa04114)
Wnt signaling pathway (hsa04310)
Axon guidance (hsa04360)
Focal adhesion (hsa04510)
Jak-STAT signaling pathway (hsa04630)
Natural killer cell mediated cytotoxicity (hsa04650)
Fc epsilon RI signaling pathway (hsa04664)
Fc gamma R-mediated phagocytosis (hsa04666)
Circadian rhythm (hsa04710)
Neurotrophin signaling pathway (hsa04722)
Regulation of actin cytoskeleton (hsa04810)
Insulin signaling pathway (hsa04910)
GnRH signaling pathway (hsa04912)
Adipocytokine signaling pathway (hsa04920)
Type II diabetes mellitus (hsa04930)
Bacterial invasion of epithelial cells (hsa05100)
Epithelial cell signaling in HP infection (hsa05120)
Shigellosis (hsa05131)
Chagas disease (hsa05142)
Pathways in cancer (hsa05200)
Endometrial cancer (hsa05213)
Prostate cancer (hsa05215)
Melanoma (hsa05218)
Acute myeloid leukemia (hsa05221)
Non-small cell lung cancer (hsa05223)
Drug repurposing [?]
None
Drugbank (The triangular compound term that is associated
with greater than or equal to genes)
Drugbank w/ drug-likeness (The triangular compound term that is associated
with greater than or equal to genes)
PharmGKB (The triangular drug term that is associated
with greater than or equal to genes)
PharmGKB w/ drug-likeness (The triangular drug term that is associated
with greater than or equal to genes)
Diseases (HGMD) (The triangular disease term that is
associated with greater than or equal to genes)
All rights reserved to BIBS laboratory, Seoul National University, Korea. |